Legislative Update: Origin Labeling, Export Finance, Drug Imports
© , Sandler, Travis & Rosenberg, P.A. Originally published in the [11/05/2019] issue of the Sandler, Travis & Rosenberg Trade Report. Reprinted by permission.
Origin Labeling. The U.S. Beef Integrity Act (S. 2744, introduced Oct. 30 by Sen. Rounds, R-S.D.) would modify the requirements for a meat food product of cattle to bear a “Product of U.S.A.” label. A press release from Rounds’ office states that this bill would ensure that this label “only goes to beef and beef products exclusively derived from one or more animals born, raised and slaughtered in the United States.” The press release explains that under current Department of Agriculture rules beef from livestock born and raised in foreign countries can be labeled as a product of the U.S. as long as it undergoes additional processing at a U.S. plant.
Export Finance. The House Financial Services Committee approved Oct. 31 the U.S. Export Finance Agency Act (H.R. 4863, introduced Oct. 28 by Rep. Waters, D-Calif.), which would rename the Export-Import Bank of the U.S. as the U.S. Export Finance Agency, reauthorize it for ten years, and make a number of reforms.
Drug Imports. The Stop Importation and Manufacturing of Synthetic Analogues Act (S. 2764 and H.R. 4963) would amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated. Specifically, this bipartisan legislation would allow substances to be temporarily or permanently added to a new category of controlled substances if their chemical structure is substantially similar to an existing controlled substance and they are expected to have the same or greater effect on the human body. It would also apply existing criminal penalties to importers, exporters, and manufacturers of such substances.